Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?

The global range and high fatality rate of the newest human coronavirus (HCoV) pandemic has made SARS-CoV-2 the focus of the scientific world. Next-generation sequencing of the viral genome and a phylogenetic analysis have shown the high homology of SARS-CoV-2 to other HCoVs that have led to local e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinderewicz, Emilia, Czelejewska, Wioleta, Jezierska-Wozniak, Katarzyna, Staszkiewicz-Chodor, Joanna, Maksymowicz, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559562/
https://www.ncbi.nlm.nih.gov/pubmed/32916812
http://dx.doi.org/10.3390/pathogens9090739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559562/
https://www.ncbi.nlm.nih.gov/pubmed/32916812
http://dx.doi.org/10.3390/pathogens9090739

Ejemplares similares